2-Ethyl-4-methyl thiazole | CAS:15679-12-6

We serve 2-Ethyl-4-methyl thiazole CAS:15679-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Ethyl-4-methyl thiazole

Chemical Name:2-Ethyl-4-methyl thiazole
CAS.NO:15679-12-6
Synonyms:2-Ethyl-4-methyl thiazole
2-Ethyl-4-methylthiazole
2-ethyl-4-methyl-1,3-thiazole
Thiazole, 2-ethyl-4-methyl-
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 173.3±9.0 °C at 760 mmHg
Molecular Formula C6H9NS
Molecular Weight 127.207
Flash Point 54.4±0.0 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like 2-Ethyl-4-methyl thiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Thiazole, 2-ethyl-4-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Thiazole, 2-ethyl-4-methyl- Use and application,Thiazole, 2-ethyl-4-methyl- technical grade,usp/ep/jp grade.


Related News: The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.3-methylpyridine-2-carbonitrile manufacturer In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank.4-(2-bromoacetyl)benzonitrile supplier Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.3,4-Dimethoxyphenylacetonitrile vendor Global Times reported that local officials had been putting up slogans in an effort to get communities to stay at home during the epidemic and to avoid people gathering together to slow and prevent the spread of the coronavirus.Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.